Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Jun-24 7:03 PM View:  | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 17-Jun-24 | Sale | 4,707 | $3.25 | $15,297.80 | (< 1%) 1.75M to 1.75M | |
| 17-Jun-24 7:03 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 14-Jun-24 | Private Sale | 1,900 | $3.30 | $6,270.00 | (< 1%) 1.75M to 1.75M | |
| 12-Jun-24 6:18 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 12-Jun-24 | Sale | 9,342 | $3.25 | $30,361.50 | (< 1%) 1.76M to 1.75M | |
| 12-Jun-24 6:18 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 11-Jun-24 | Sale | 5,752 | $3.26 | $18,744.20 | (< 1%) 1.77M to 1.76M | |
| 12-Jun-24 6:18 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 10-Jun-24 | Private Sale | 9,577 | $3.30 | $31,604.10 | (< 1%) 1.78M to 1.77M | |
| 07-Jun-24 6:59 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 07-Jun-24 | Sale | 1,740 | $3.26 | $5,663.80 | (< 1%) 1.78M to 1.78M | |
| 07-Jun-24 6:59 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 06-Jun-24 | Sale | 4,284 | $3.29 | $14,104.20 | (< 1%) 1.78M to 1.78M | |
| 07-Jun-24 6:59 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 05-Jun-24 | Private Sale | 6,291 | $3.30 | $20,760.30 | (< 1%) 1.79M to 1.78M | |
| 01-May-24 7:15 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 01-May-24 | Sale | 20,315 | $4.21 | $85,473.50 | (1%) 1.8M to 1.78M | |
| 01-May-24 7:15 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 30-Apr-24 | Sale | 90 | $4.97 | $447.75 | (< 1%) 1.8M to 1.8M | |
| 01-May-24 7:15 PM View: | University Of Texas/texas A... 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 29-Apr-24 | Private Sale | 10,746 | $4.95 | $53,181.70 | (< 1%) 1.81M to 1.8M | |
| 06-Mar-24 5:06 PM View: | Windsor James Brian President and COO | Aileron Therapeutics, Inc. (ALRN) | 05-Mar-24 | Option Exercise | 2,000 | -- | -- | 37% 5.35K to 7.35K | |
| 18-Dec-23 5:56 PM View: | Windsor James Brian President and COO | Aileron Therapeutics, Inc. (ALRN) | 15-Dec-23 | Purchase | 225 | $3.37 | $758.25 | 4% 5.12K to 5.35K | |
| 21-Nov-23 4:43 PM View: | Windsor James Brian President and COO | Aileron Therapeutics, Inc. (ALRN) | 20-Nov-23 | Purchase | 5,076 | $1.97 | $9,987.03 | 11035% 46 to 5.12K | |
| 08-Jan-21 4:15 PM View: | Satter Muneer A See Remarks Director | Aileron Therapeutics, Inc. (ALRN) | 08-Jan-21 | Private Purchase | 9,000,000 | $1.10 | $9,900,000.00 | 118% 7.61M to 16.61M | |
| 17-Jun-20 4:31 PM View: | Ambros Reinhard J. Director | Aileron Therapeutics, Inc. (ALRN) | 15-Jun-20 | Market Purchase | 5,800 | $1.22 | $7,076.00 | 100% 0 to 5.8K | (14%) |
| 09-Jun-20 8:23 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 08-Jun-20 | Market Purchase | 227,272 | $1.10 | $249,999.00 | 104% 218.19K to 445.46K | (5%) |
| 09-Jun-20 8:22 PM View: | Satter Muneer A Director 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 08-Jun-20 | Market Purchase | 3,700,000 | $1.10 | $4,070,000.00 | 95% 3.91M to 7.61M | (5%) |
| 18-Nov-19 4:15 PM View: | Bailey Jeffrey Allen Director | Aileron Therapeutics, Inc. (ALRN) | 15-Nov-19 | Market Purchase | 39,142 | $0.51 | $19,962.40 | 109% 35.75K to 74.89K | 100% |
| 18-Nov-19 4:15 PM View: | Bailey Jeffrey Allen Director | Aileron Therapeutics, Inc. (ALRN) | 14-Nov-19 | Market Purchase | 15,858 | $0.51 | $8,087.58 | 80% 19.89K to 35.75K | 100% |
| 14-Nov-19 4:23 PM View: | Bailey Jeffrey Allen Director | Aileron Therapeutics, Inc. (ALRN) | 12-Nov-19 | Market Purchase | 19,894 | $0.53 | $10,543.80 | 100% 0 to 19.89K | 90% |
| 16-Sep-19 4:55 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 13-Sep-19 | Market Purchase | 25,000 | $0.97 | $24,255.00 | 13% 193.19K to 218.19K | 5% |
| 16-Sep-19 4:55 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 12-Sep-19 | Market Purchase | 88,145 | $0.98 | $86,249.90 | 84% 105.04K to 193.19K | 3% |
| 05-Sep-19 4:09 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 04-Sep-19 | Market Purchase | 23,225 | $0.71 | $16,582.70 | 28% 81.82K to 105.04K | 43% |
| 04-Sep-19 4:14 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 03-Sep-19 | Market Purchase | 13,466 | $0.70 | $9,427.55 | 20% 68.35K to 81.82K | 48% |
| 04-Sep-19 4:14 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 30-Aug-19 | Market Purchase | 15,000 | $0.73 | $10,968.00 | 28% 53.35K to 68.35K | 41% |
| 03-Sep-19 5:17 PM View: | von Rickenbach Josef H Director | Aileron Therapeutics, Inc. (ALRN) | 29-Aug-19 | Market Purchase | 3,600 | $0.77 | $2,770.92 | 7% 49.75K to 53.35K | 32% |
| 20-Aug-19 4:17 PM View: | Vukovic Vojo SVP, Chief Medical Officer | Aileron Therapeutics, Inc. (ALRN) | 16-Aug-19 | Market Purchase | 75,000 | $0.59 | $44,452.50 | 100% 0 to 75.0K | 74% |
| 15-Aug-19 4:16 PM View: | Gregory Kathryn SVP, Chief Business Officer | Aileron Therapeutics, Inc. (ALRN) | 13-Aug-19 | Market Purchase | 45,000 | $0.64 | $29,025.00 | 100% 0 to 45.0K | 60% |
| 02-Apr-19 8:23 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 01-Apr-19 | Market Sale | 20,610 | $1.90 | $39,159.00 | (< 1%) 2.1M to 2.08M | 45% |
| 02-Apr-19 8:23 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 29-Mar-19 | Market Sale | 106,540 | $1.85 | $197,099.00 | (5%) 2.21M to 2.1M | 43% |
| 15-Mar-19 5:25 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 15-Mar-19 | Market Sale | 43,800 | $1.92 | $84,096.00 | (2%) 2.25M to 2.21M | 46% |
| 15-Mar-19 5:25 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 14-Mar-19 | Market Sale | 13,800 | $1.88 | $25,944.00 | (< 1%) 2.26M to 2.25M | 44% |
| 15-Mar-19 5:25 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 13-Mar-19 | Market Sale | 132,738 | $2.12 | $281,405.00 | (6%) 2.4M to 2.26M | 51% |
| 22-Aug-18 4:34 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 20-Aug-18 | Market Sale | 20,388 | $2.30 | $46,892.40 | (< 1%) 2.42M to 2.4M | 55% |
| 20-Aug-18 5:12 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 17-Aug-18 | Market Sale | 8,700 | $2.10 | $18,270.00 | (< 1%) 2.43M to 2.42M | 51% |
| 20-Aug-18 5:12 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 16-Aug-18 | Market Sale | 8,808 | $2.10 | $18,496.80 | (< 1%) 2.43M to 2.43M | 51% |
| 16-Aug-18 4:18 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 15-Aug-18 | Market Sale | 2,635 | $2.15 | $5,665.25 | (< 1%) 2.44M to 2.43M | 52% |
| 16-Aug-18 4:18 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 14-Aug-18 | Market Sale | 3,300 | $2.26 | $7,458.00 | (< 1%) 2.44M to 2.44M | 54% |
| 14-Aug-18 5:05 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 13-Aug-18 | Market Sale | 1,600 | $2.36 | $3,776.00 | (< 1%) 2.44M to 2.44M | 56% |
| 14-Aug-18 5:05 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 10-Aug-18 | Market Sale | 5,615 | $2.44 | $13,700.60 | (< 1%) 2.45M to 2.44M | 58% |
| 14-Aug-18 7:38 PM View: | Longenecker John P Phd President and CEO | Aileron Therapeutics, Inc. (ALRN) | 10-Aug-18 | Market Purchase | 10,000 | $2.45 | $24,500.00 | 100% 0 to 10.0K | (58%) |
| 10-Aug-18 4:29 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 09-Aug-18 | Market Sale | 235 | $2.48 | $582.80 | (< 1%) 2.45M to 2.45M | 58% |
| 10-Aug-18 4:29 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 08-Aug-18 | Market Sale | 1,000 | $2.78 | $2,780.00 | (< 1%) 2.45M to 2.45M | 63% |
| 08-Aug-18 4:21 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 07-Aug-18 | Market Sale | 1,739 | $2.97 | $5,164.83 | (< 1%) 2.45M to 2.45M | 65% |
| 08-Aug-18 4:21 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 06-Aug-18 | Market Sale | 2,942 | $3.02 | $8,884.84 | (< 1%) 2.45M to 2.45M | 66% |
| 06-Aug-18 4:22 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 02-Aug-18 | Market Sale | 4,702 | $3.33 | $15,657.70 | (< 1%) 2.46M to 2.45M | 69% |
| 02-Aug-18 4:33 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 01-Aug-18 | Market Sale | 8,181 | $3.22 | $26,342.80 | (< 1%) 2.47M to 2.46M | 68% |
| 02-Aug-18 4:33 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 31-Jul-18 | Market Sale | 4,500 | $3.07 | $13,815.00 | (< 1%) 2.47M to 2.47M | 66% |
| 31-Jul-18 4:16 PM View: | Novartis Bioventures Ltd 10% Owner | Aileron Therapeutics, Inc. (ALRN) | 30-Jul-18 | Market Sale | 2,000 | $3.27 | $6,540.00 | (< 1%) 2.47M to 2.47M | 68% |
